发明公开
EP0193330A3 Hyaluronidase, isolation and pharmaceutical use thereof, and pharmaceutical and veterinary formulations containing it
失效
HYALURONIDASE,隔离和药物使用,以及含有它的药物和兽医配方
- 专利标题: Hyaluronidase, isolation and pharmaceutical use thereof, and pharmaceutical and veterinary formulations containing it
- 专利标题(中): HYALURONIDASE,隔离和药物使用,以及含有它的药物和兽医配方
-
申请号: EP86301092申请日: 1986-02-17
-
公开(公告)号: EP0193330A3公开(公告)日: 1988-07-20
- 发明人: Sawyer, Roy Thomas , Edwards, Jeffrey
- 申请人: Biopharm (UK) Ltd.
- 专利权人: Biopharm (UK) Ltd.
- 当前专利权人: Biopharm (UK) Ltd.
- 优先权: GB8504025 19850216
- 主分类号: C12N09/26
- IPC分类号: C12N09/26 ; A61K37/54 ; C12Q01/34
摘要:
The hyaluronidase, which is a hyaluronic acid-specific endo-B-glucuronidase, having a molecular weight of about 28,500 in non-reduced form, is derived from buffalo leeches (that is, leeches of the sub-family Hirudinariinae, such as the species Hirudinaria manillensis or Poecilobdella granulosa) The hyaluronidase, which cleaves hyaluronic acid, but not chondroitin, chondroitin -4- sulphate, chondroitin -6- sulphate or heparin, is considerably more stable at high temperatures and extremes of pH than known leech hyaluronidase. It has a wide range of uses where breakdown of hyaluronic acid is required; of particular interest is in pharmaceutical or veterinary formulations, either as an active agent or a spreading or percutaneous factor. The hyaluronidase is useful for stimulating flow of physiological fluids in the eye (for example, in the treatment of glaucoma).
信息查询